Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11891426 CD19 variants

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
December 14, 2018
0
Date of Patent
February 6, 2024
0
Patent Application Number
16954002
0
Patent Citations
‌
US Patent 9120853 Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof
0
‌
US Patent 10508143 Compositions and methods for treatment of cancer
0
‌
US Patent 10669349 Compositions and methods for treatment of cancer
0
‌
US Patent 8394411 Papillomavirus pseudoviruses for detection and therapy of tumors
0
‌
US Patent 8470528 Methods and compositions related to adenoassociated virus-phage particles
0
‌
US Patent 8513390 Modified antibody compositions, methods of making and using thereof
0
Patent Inventor Names
Roy Lobb
0
Benjamin Hackel
0
Justin Klesmith
0
Paul Rennert
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11891426
0
Patent Primary Examiner
‌
Laura B Goddard
0
CPC Code
‌
A61K 45/06
0
‌
A61K 2039/505
0
‌
A61K 39/0011
0
‌
A61K 39/001112
0
‌
A61K 2039/5156
0
‌
A61K 2039/5158
0
‌
A61K 38/00
0
‌
A61K 39/0008
0
‌
A61P 35/00
0
‌
C07K 14/70503
0
•••

Find more entities like US Patent 11891426 CD19 variants

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo